‘EXPERIENCE AND LEARNINGS FROM IMPLEMENTING IMPROVEMENTS IN REFERRAL MANAGEMENT AND DEMAND
With
Nalani Cox,
Program Manger (Assistant Director of Nursing ADON)
Referral Strategy and ”PerformanceGold Coast Health, Queensland Health
PEOPLE IN HEALTH CARE SEGMENT
Filmed in Southport (Gold Coast) | May 2025
Nalani Cox joined Gold Coast Health in 2019 as a Nurse Manager focused on improving referral management processes within the outpatient environment through the implementation of the Clinical Prioritisation Criteria. This work became a focus point for the organisation in 2020 when Nalani led an organisational wide change project introducing Smart Referrals, Refer Your Patient website and HealthPathways which has culminated in her position as the ADON of the Referral Strategy and Performance Department.
Here she continues to improve and support the continuum of care and create improved clinical safety and transparency of referral management processes across Gold Coast Health. Nalani believes that working collaboratively with external care providers and staff across all levels of the organisation to drive change management, clinical redesign and promote shared understanding is critical in improving the patient journey through our complex health environment.
Prior to commencing this work, Nalani participated in the Australian College of Nursing (ACN) Mid-Career Nurse Leadership Program, which she describes as a catalyst for some of the most significant career achievements to date. Nalani is the deputy chair of ACN Brisbane Region Leadership team.
Source: Supplied
-
Recognising service in health regulation
In April 2023, Professor John Skerritt retired from his position of Deputy Secretary Health Products Regulation Group, a role he has been in since 2012. During his time at the TGA he had line responsibility for over 1200 staff involved in the regulation of therapeutic goods, regulation of gene technology and industrial chemicals and control of drug import, export and production.
At this year’s ARCS 2023 Conference, ARCS Australia CEO Dr Shanny Dyer paid tribute to Professor Skerritt and his service to the Australian health industry. She led a tribute with fellow industry heads, Elizabeth de Somer, CEO, Medicines Australia, Anne Harris, Managing Director, Pfizer Australia & New Zealand, Deon Schoombie, CEO, Consumer Healthcare Products Australia, Ian Burgess, CEO, Medical Technology Association of Australia and Arthur Brandwood, President ARCS Australia.
-
Jamie Stanistreet talks Medical Technology
Jamie Stanistreet
Retired Managing Director Medtronic Australia and New Zealand
talks Medical Technology in Australia and the Asia-Pacific -
Maximising benefits, minimising harms in population health screening
Population screening is an important contributor to advancing health outcomes through the early detection of and successful intervention for chronic disease. The evolution of science, technology and evidence relating to diseases which are or may be amenable to a population screening approach deserve broad discussion and the sharing of expertise and evidence. They also warrant close scrutiny in context of health policy and health resource allocation considerations.
In March, Public Health Association of Australia (PHAA) convened Screening Conference Conference 2025 with the theme of ‘Population Screening for Chronic Disease – Maximising Benefits, Minimising Harms’.
